Effect of Whole Body Vibration on Walking Performance in Elderly Hemodialysis Patients

Hemodialysis Clinical Trial

Official title:

A Randomized Controlled Trial to Evaluate the Efficacy of Whole Body Vibration on Walking Performance in Elderly Hemodialysis Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04774731
• Other study ID #: WBV-HD
• Status: Completed
• Phase: N/A
• Start date: April 1, 2021
• Est. completion date: March 30, 2022

Study information

• Verified date: September 2022
• Source: Osaka University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of whole body vibration for 12 weeks on walking performance in elderly hemodialysis patients.

Description:

This is a multicenter, prospective, randomized controlled trial. Eligible subjects will be randomized in a 1:1 ratio to a whole-body vibration (WBV) group or controlled group. Patients in a WBV group will receive WBV training three times a week before initiation of dialysis sessions for 12 weeks. The primary outcome of the study will be the change in walking performance assessed by the timed up and go test.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 98
• Est. completion date: March 30, 2022
• Est. primary completion date: March 30, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Undergoing maintenance hemodialysis three times a week .

Exclusion Criteria:

• Having difficulty in walking by oneself.

• Having difficulty in receiving whole body vibration training because of cognitive impairment.

• History of fracture of lower limb within 1 year.

• History of total hip arthroplasty.

• Unsuitable for participant in the trial by an attending physician.

Related Conditions & MeSH terms

• Hemodialysis

Intervention

Other:
• Whole Body Vibration
Receiving WBV training three times a week before initiation of dialysis sessions for 12 weeks. Subjects stand on a platform of WBV for 3 minutes in every training session.

Locations

Country	Name	City	State
Japan	Osaka University Hospital	Suita	Osaka

Sponsors (1)

Lead Sponsor	Collaborator
Osaka University

Country where clinical trial is conducted

Japan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in the timed up and go test		12 weeks after starting intervention
Secondary	Change in the one-leg standing test		12 weeks after starting intervention
Secondary	Change in the 30-second chair-stand test		12 weeks after starting intervention